Finance

Lists
IBIO:NASDAQ
Ibio Inc
US$ ०.७८
-०.१३%
(-०.००१००) 1D
US$ ०.७६
-२.८३% (-०.०२२)
After hours
Closed: अक्टोबर १४, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBIO...
Open
US$ ०.७८
High
US$ ०.८१
Low
US$ ०.७३
Mkt. cap
५.०३ करोड
Avg. vol.
७.५२ लाख
Volume
०.००
52-wk high
US$ ३.८२
52-wk low
US$ ०.७३
EPS
-US$ ०.३२
Beta
१.२६
Shares outstanding
६.४३ करोड
No. of employees
२३
Open
US$ ०.७८
High
US$ ०.८१
Low
US$ ०.७३
Mkt. cap
५.०३ करोड
Avg. vol.
७.५२ लाख
Volume
०.००
52-wk high
US$ ३.८२
52-wk low
US$ ०.७३
EPS
-US$ ०.३२
Beta
१.२६
Shares outstanding
६.४३ करोड
No. of employees
२३
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
१२ मिनेट पहिले
Why Pegasystems Fell Even As Sales Rose
Investor's Business Daily
Investor's Business Daily
·
४ घण्टा पहिले
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
About Ibio Inc
CEO-
Employees२३
Founded२००८
Headquarters-
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to IBIO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for IBIO in the last 3 months.
Highest
Current US$ ०.७८
US$ ७.०० (+७९६.५२%)
Average
US$ ६.०० (+६६८.४४%)
Lowest
US$ ५.०० (+५४०.३७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Reiterated
US$ ७.००
+७९६.५%
10/02/2026
William Wood
B. Riley Securities
Buy
Initiated
US$ ६.००
+६६८.४%
08/31/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
US$ ५.००
+५४०.४%
08/28/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
US$ ५.००
+५४०.४%
07/01/2026
Martin Auster
Raymond James
Buy
Initiated
US$ ५.००
+५४०.४%
06/08/2026
Roanna Ruiz
Leerink Partners
Buy
Maintained
US$ ६.००
+६६८.४%
05/15/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
US$ ६.००
+६६८.४%
05/14/2026
Catherine Novack
JonesTrading
Buy
Maintained
US$ ७.००
+७९६.५%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.०० लाख
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
३५.५० लाख
४२.८० लाख
३२.५४ लाख
८५.५९ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२५.०१ लाख
५१.६५ लाख
५१.११ लाख
-२१.८२ लाख
Operating expense
६०.५१ लाख
९४.४५ लाख
८३.६५ लाख
६३.७७ लाख
Total operating expenses
६०.५१ लाख
९४.४५ लाख
८३.६५ लाख
६३.७७ लाख
Operating income
-५९.५१ लाख
-९४.४५ लाख
-८३.६५ लाख
-६३.७७ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-५७.२० लाख
-८९.९३ लाख
-७७.३० लाख
-१.०६ करोड
EBT excluding unusual items
-५७.२० लाख
-८९.९३ लाख
-७७.३० लाख
-५५.९८ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-५७.२० लाख
-८९.९३ लाख
-७७.३० लाख
-१.०६ करोड
Net profit margin
-५,७२०.००%
-
-
-
Earnings per share
-०.११
-०.०९
-०.०६
-०.०७
Interest and investment income
२.६७ लाख
४.९३ लाख
६.५७ लाख
७.७९ लाख
Interest expense
-३६.०० हजार
-४१.०० हजार
-२२.०० हजार
-
Net interest expenses
२.३१ लाख
४.५२ लाख
६.३५ लाख
७.७९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-५७.५५ लाख
-९२.९९ लाख
-८२.१३ लाख
-६२.२५ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू